Trade Biogen Inc. - BIIB CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.26 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 140.46 |
| Open | 141.1 |
| 1-Year Change | -43.51% |
| Day's Range | 140.56 - 141.78 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | 140.86 | 0.01 | 0.01% | 140.85 | 141.89 | 140.39 |
| Jan 17, 2025 | 140.45 | -0.81 | -0.57% | 141.26 | 142.92 | 139.95 |
| Jan 16, 2025 | 141.03 | 0.55 | 0.39% | 140.48 | 142.34 | 139.89 |
| Jan 15, 2025 | 140.81 | -3.59 | -2.49% | 144.40 | 146.21 | 140.81 |
| Jan 14, 2025 | 142.88 | -6.07 | -4.08% | 148.95 | 149.56 | 142.35 |
| Jan 13, 2025 | 149.58 | 0.71 | 0.48% | 148.87 | 150.37 | 145.37 |
| Jan 10, 2025 | 148.67 | 1.65 | 1.12% | 147.02 | 149.90 | 147.02 |
| Jan 8, 2025 | 150.68 | -0.68 | -0.45% | 151.36 | 152.66 | 149.85 |
| Jan 7, 2025 | 153.16 | 0.21 | 0.14% | 152.95 | 156.21 | 152.00 |
| Jan 6, 2025 | 152.81 | 1.79 | 1.19% | 151.02 | 153.47 | 151.02 |
| Jan 3, 2025 | 152.02 | 2.27 | 1.52% | 149.75 | 152.78 | 148.71 |
| Jan 2, 2025 | 149.80 | -3.74 | -2.44% | 153.54 | 153.83 | 149.61 |
| Dec 31, 2024 | 152.75 | 2.81 | 1.87% | 149.94 | 152.96 | 149.94 |
| Dec 30, 2024 | 150.07 | 0.52 | 0.35% | 149.55 | 151.07 | 147.66 |
| Dec 27, 2024 | 151.11 | 2.96 | 2.00% | 148.15 | 151.65 | 147.40 |
| Dec 26, 2024 | 149.75 | 2.35 | 1.59% | 147.40 | 150.52 | 147.14 |
| Dec 24, 2024 | 148.41 | 1.56 | 1.06% | 146.85 | 149.21 | 146.69 |
| Dec 23, 2024 | 148.73 | 3.51 | 2.42% | 145.22 | 149.84 | 144.95 |
| Dec 20, 2024 | 145.90 | 0.95 | 0.66% | 144.95 | 147.68 | 144.95 |
| Dec 19, 2024 | 146.94 | 0.44 | 0.30% | 146.50 | 148.15 | 145.07 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Biogen Company profile
Biogen Inc. (BIIB) is a biotechnology company in the field of neurological and neurodegenerative diseases.
Established in 1978 and headquartered in Cambridge, Massachusetts, Biogen has devoted its scientific research to defeating neurological diseases, like multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
With the aid of some of the world’s leading neuroscientists and neurologists, Biogen has sought treatments against common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
The use of advanced technologies and engineering skills has enabled Biogen to bring effective medicines to the market. The company’s products include SPINRAZA for the treatment of SMA; TECFIDERA, AVONEX, FAMPYRA, VUMERITY and TYSABRI for multiple sclerosis; ADUHELM for Alzheimer’s disease; and FUMADERM for the treatment of severe plaque psoriasis.
Biogen has made an agreement with Genentech, a member of the Roche Group for business and financial rights, with respect to RITUXAN, GAZYVA and OCREVUS. It’s constantly looking at ways to improve its research and development to compete against other biotech giants like Pfizer Inc (PFE), Johnson & Johnson (JNJ) and Amgen (AMGN).
Biogen went public in September 1991. It trades on the Nasqaq under the ticker ‘BIIB’.
| Industry: | Biopharmaceuticals |
225 Binney Street
CAMBRIDGE
MASSACHUSETTS 02142
US
News
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 680,000+ traders worldwide that chose to trade with Capital.com